Social and psychological risk factors for decreased adherence among patients with atrial fibrillation
- 作者: Troshina D.1, Andreev D.2, Fomicheva A.1, Volovchenko A.1, Volel B.1,3
-
隶属关系:
- Sechenov First Moscow State Medical University (Sechenov University)
- Sechenov First Moscow State Medical University
- Mental Health Research Center
- 期: 卷 94, 编号 10 (2022)
- 页面: 1197-1203
- 栏目: Reviews
- URL: https://journals.rcsi.science/0040-3660/article/view/111050
- DOI: https://doi.org/10.26442/00403660.2022.10.201905
- ID: 111050
如何引用文章
全文:
详细
Adherence has a direct impact on reducing the effectiveness of atrial fibrillation therapy and increasing the risk of thromboembolic events. Among the factors involved in the decrease of adherence, the social and psychological characteristics of patients remain insufficiently studied. At the same time, the available publications allow us to conclude that there are markers of the risk of reduced adherence in patients with atrial fibrillation, which include age, cognitive impairment, psychoemotional disorders (including depression and anxiety) and specific behavioral patterns.
作者简介
Daria Troshina
Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: troshina_d_v@staff.sechenov.ru
ORCID iD: 0000-0002-5046-6699
канд. мед. наук, специалист по научно-методической работе Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowDenis Andreev
Sechenov First Moscow State Medical University
Email: andreev_d_a@staff.sechenov.ru
ORCID iD: 0000-0002-0276-7374
д-р мед. наук, проф., зав. каф. кардиологии, функциональной и ультразвуковой диагностики Института клинической медицины им. Н.В. Склифосовского, дир. клиники кардиологии УКБ №1 ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowAnastasia Fomicheva
Sechenov First Moscow State Medical University (Sechenov University)
Email: nastassja.fomicheva@gmail.com
ORCID iD: 0000-0003-3624-0981
аспирант каф. психиатрии и психосоматики Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowAlexey Volovchenko
Sechenov First Moscow State Medical University (Sechenov University)
Email: volovchenko_a_n@staff.sechenov.ru
ORCID iD: 0000-0002-0923-735X
канд. мед. наук, зав. кардиологическим отд-нием клиники кардиологии УКБ №1 ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowBeatrice Volel
Sechenov First Moscow State Medical University (Sechenov University); Mental Health Research Center
Email: volel_b_a@staff.sechenov.ru
ORCID iD: 0000-0003-1667-5355
д-р мед. наук, проф., проф. каф. психиатрии и психосоматики, дир. Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет), ст. науч. сотр. ФГБНУ НЦПЗ
俄罗斯联邦, Moscow; Moscow参考
- Chugh S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. doi: 10.1161/CIRCULATIONAHA.113.005119
- Dai H, Zhang Q, Much A, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes. 2021;7(6):574-82. doi: 10.1093/ehjqcco/qcaa061
- Мареев Ю.В., Поляков Д.С., Виноградова Н.Г., и др. ЭПОХА: Эпидемиология фибрилляции предсердий в репрезентативной выборке Европейской части Российской Федерации. Кардиология. 2022;62(4):12-9 [Mareev YuV, Polyakov DS, Vinogradova NG, et al. Epidemiology of atrial fibrillation in a representative sample of the European part of the Russian Federation. Analysis of EPOCH-CHF Study. Kardiologiia. 2022;62(4):12-9 (in Russian)]. doi: 10.18087/cardio.2022.4.n1997
- Беленков Ю.Н., Шакарьянц Г.А., Хабарова Н.В., Ан Г.В. Антикоагулянтная терапия у пожилых пациентов с фибрилляцией предсердий. Кардиология. 2018;58(10):45-52 [Belenkov YuN, Shakaryants GA, Khabarova NV, An GV. Anticoagulant Therapy in Elderly Patients With Atrial Fibrillation. Kardiologiia. 2018;58(10):45-52 (in Russian)]. doi: 10.18087/cardio.2018.10.10177
- Бокерия Л.А., Полунина А.Г., Лефтерова Н.П., и др. Фибрилляция предсердий, дилатация левых камер сердца: пусковые механизмы развития когнитивных нарушений у кардиологических пациентов. Креативная кардиология. 2015;9(1):38-45 [Bockeria LA, Polunina AG, Lefterova NF, et al. Atrium fibrillation and enlargement of left heart chambers: pathological mechanisms of cognitive dysfunction in cardiologic patients. Creative Cardiology. 2015;9(1):38-45 (in Russian)]. doi: 10.15275/kreatkard.2015.01.04
- Диагностика и лечение фибрилляции предсердий. Клинические рекомендации, 2017. Режим доступа: https://racvs.ru/clinic/files/2017/Atrial-Fibrillation.pdf. Ссылка активна на 26.09.2022 [Diagnostika i lechenie fibrilliatsii predserdii. Klinicheskie rekomendatsii, 2017. Available at: https://racvs.ru/clinic/files/2017/Atrial-Fibrillation.pdf. Accessed: 26.09.2022 (in Russian)].
- Salmasi S, Loewen P, Tandun R, et al. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open. 2020;10(4):e034778. doi: 10.1136/bmjopen-2019-034778
- Jankowska-Polańska B, Lomper K, Alberska L, et al. Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation. J Geriatr Cardiol. 2016;13(7):559. doi: 10.11909/j.issn.1671-5411.2016.07.006
- Obamiro K, Chalmers L, Lee K, et al. Adherence to oral anticoagulants in atrial fibrillation: An Australian survey. Cardiovasc Pharm Ther. 2018;23:337-43. doi: 10.1177/1074248418770201
- Seong H, Lee K, Kim B, Son Y. Cognitive impairment is independently associated with non-adherence to antithrombotic therapy in older patients with atrial fibrillation. Int J Environ Res Public Health. 2019;16(15):2698. doi: 10.3390/ijerph16152698
- Raparelli V, Proietti M, Cangemi R, et al. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Thromb Haemost. 2017;117(02):209-18. doi: 10.1160/TH16-10-0757
- Cramer J, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-7. doi: 10.1111/j.1524-4733.2007.00213.x
- Tomasdottir M, Friberg L, Hijazi Z, et al. Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation. Clin Cardiol. 2019;42(10):1003-9. doi: 10.1002/clc.23257
- Lip G, Laroche C, Popescu M, et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. EP Europace. 2015;17(12):1777-86. doi: 10.1093/europace/euv269
- Thompson L, Maddox T, Lei L, et al. Sex differences in the use of oral anticoagulants for atrial fibrillation: a report from the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry. J Am Heart Assoc. 2017;6(7):e005801. doi: 10.1161/JAHA.117.005801
- Eckman M, Wise R, Leonard A, et al. Racial and sex differences in optimizing anticoagulation therapy for patients with atrial fibrillation. American Heart Journal Plus: Cardiology Research and Practice. 2022;18:100170. doi: 10.1016/j.ahjo.2022.100170
- Charlton A, Vidal X, Sabaté M, et al. Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation. J Manag Care Specy Pharm. 2021;27(9):1210-20. doi: 10.18553/jmcp.2021.27.9.1210
- Bartolazzi F, Ribeiro A, de Sousa W, et al. Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study. J Thromb Thrombolysis. 2021;52(4):1074-80. doi: 10.1007/s11239-021-02432-4
- Ferguson C, Inglis S, Newton P, et al. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. J Clin Nurs. 2017;26(23-24):4325-34. doi: 10.1111/jocn.13759
- Cabellos-Garcia A, Martinez-Sabater A, Castro-Sanchez E, et al. Relation between health literacy, self-care and adherence to treatment with oral anticoagulants in adults: a narrative systematic review. BMC Public Health. 2018;18(1):1-12. doi: 10.1186/s12889-018-6070-9
- Lemstra M, Nwankwo C, Bird Y, Moraros J. Primary nonadherence to chronic disease medications: a meta-analysis. Patient Prefer Adherence. 2018;12:721. doi: 10.2147/PPA.S161151
- Mandalenakis Z, Von Koch L, Eriksson H, et al. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace. 2015;17(7):1018-22. doi: 10.1093/europace/euv036
- Friberg L, Rosenqvist M, Lip G. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500-10. doi: 10.1093/eurheartj/ehr488
- LaMori J, Mody S, Gross H, et al. Burden of comorbidities among patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2013;7(2):53-62. doi: 10.1177/17539447124641
- Деменко Т.Н., Чумакова Г.А., Чугунова Ю.В. Особенности когнитивной функции у пациентов с фибрилляцией предсердий. Анналы аритмологии. 2015;12(4):215-24 [Demenko TN, Chumakova GA, Chugunova YV. Features of cognitive function in patients with atrial fibrillation. Annaly aritmologii. 2015;12(4):215-24 (in Russian)]. doi: 10.15275/annaritmol.2015.4.3
- Rohde D, Merriman N, Doyle F, et al. Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke. PloS One. 2017;12(12):e0189339. doi: 10.1371/journal.pone.0189339
- Кобалава Ж.Д., Лазарев П.В., Федорова Д.Н. Когнитивная дисфункция на фоне фибрилляции предсердий: клинико-патогенетические ассоциации, диагностика и профилактика, аспекты применения антикоагулянтной терапии. Кардиология. 2019;59(10):66-77 [Kobalava ZD, Lazarev PV, Fedorova DN. Cognitive Dysfunction at the Background of Atrial Fibrillation: Clinical-Pathological Aspects, Diagnostics and Prevention, Issues of the Use of the Application of Anticoagulant Therapy. Kardiologiia. 2019;59(10):66-77 (in Russian)]. doi: 10.18087/cardio.2019.10.n612
- Gallagher A, Rietbrock S, Plumb J, Van Staa T. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemostas. 2008;6(9):1500-6. doi: 10.1111/j.1538-7836.2008.03059.x
- Castellucci L, Shaw J, van der Salm K, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thrombosis Res. 2015;136(4):727-31. doi: 10.1016/j.thromres.2015.07.007
- Emren S, Şenöz O, Bilgin M, et al. Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR. Clin Appl Thromb Hemost. 2018;24(3):525-31. doi: 10.1177/1076029617693940
- Zielinski G, van Rein N, Teichert M, et al. Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: a surveillance study. Res Pract Thromb Haemost. 2020;4(1):141-53. doi: 10.1002/rth2.12261
- Smith D, Lovell J, Weller C, et al. A systematic review of medication non-adherence in persons with dementia or cognitive impairment. PloS One. 2017;12(2):e0170651. doi: 10.1371/journal.pone.0170651
- Patel D, McConkey N, Sohaney R, et al. A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol. 2013;2013:159850. doi: 10.1155/2013/159850
- Polikandrioti M, Koutelekos I, Vasilopoulos G, et al. Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors. Cardiol Res Pract. 2018;2018:7408129. doi: 10.1155/2018/7408129
- Søgaard M, Skjøth F, Kjældgaard J, et al. Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study. BMJ Open. 2017;7(12):e018209. doi: 10.1136/bmjopen-2017-018209
- Wu M, Shen L, Wang Q, et al. Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China. Front Public Health. 2022;9:758874. doi: 10.3389/fpubh.2021.758874
- Walker E, McGee R, Druss B. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334-41. doi: 10.1001/jamapsychiatry.2014.2502
- Jayatilleke N, Hayes R, Dutta R, et al. Contributions of specific causes of death to lost life expectancy in severe mental illness. Eur Psychiatry. 2017;43:109-15. doi: 10.1016/j.eurpsy.2017.02.487
- McGrady A, McGinnis R, Badenhop D, et al. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prevn. 2009;29(6):358-64. doi: 10.1097/HCR.0b013e3181be7a8f
- Fenger-Grøn M, Vestergaard C, Frost L, et al. Depression and uptake of oral anticoagulation therapy in patients with atrial fibrillation: a Danish nationwide cohort study. Medical Care. 2020;58(3):216-24. doi: 10.1097/MLR.0000000000001268
- Reading S, Black M, Singer D, et al. Risk factors for medication non-adherence among atrial fibrillation patients. BMC Cardiovasc Disord. 2019;19(1):38. doi: 10.1186/s12872-019-1019-1
- Bauer LK, Caro MA, Beach SR, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012;109(9):1266-71. doi: 10.1016/j.amjcard.2011.12.017
- Suzuki T, Shiga T, Omori H, et al. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. J Cardiol. 2017;70(3):238-43. doi: 10.1016/j.jjcc.2016.11.009
- Taylor E, O'Neill M, Hughes L, et al. Examining adherence to medication in patients with atrial fibrillation: the role of medication beliefs, attitudes, and depression. J Cardiovasc Nurs. 2020;35(4):337-46. doi: 10.1097/JCN.0000000000000650
- Teppo K, Jaakkola J, Airaksinen K, et al. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study. J Am Heart Assoc. 2022;11(6):e024119. doi: 10.1161/JAHA.121.024119
- Miyazaki M, Nakashima A, Nakamura Y, et al. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: an observational cross-sectional pilot study. PloS One. 2018;13(9):e0204814. doi: 10.1371/journal.pone.0204814
- Lane D, Meyerhoff J, Rohner U, Lip G. Patients’ perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment: An international survey. TH Open. 2018;2(03):e233-41. doi: 10.1055/s-0038-1666803
- Алёхин А.Н., Трифонова Е.А., Лебедев Д.С., и др. Психологические проблемы в аритмологии (на модели фибрилляции предсердий). Вестник аритмологии. 2011;63:45-54 [Alekhin AN, Trifonova EA, Lebedev DS, et al. Psuchological problems in arrhythmology (on a model of atrial fibrillation). Vestnik aritmologii. 2011;63:45-54 (in Russian)].
- Streur M, Ratcliffe SJ, Callans D, et al. Atrial fibrillation symptom clusters and associated clinical characteristics and outcomes: A cross-sectional secondary data analysis. Eur J Cardiovasc Nurs. 2018;17(8):707-16. doi: 10.1177/1474515118778445